CLINICO-PATHOGENICAL ASPECTS OSTEODEFICIENCY AT OSTEOARTHRITIS IN COMBINATION WITH CHRONIC PANCREATITIS
DOI:
https://doi.org/10.11603/1811-2471.2017.v0.i2.7725Keywords:
osteoarthritis, osteopenia, osteoporosis, chronic pancreatitis, antioxidant protection, lipid peroxidation, hydroxyproline.Abstract
SUMMARY. The article deals with modern views on the problem of comorbidity of osteoarthritis, chronic pancreatitis and osteodefiсiency. Dual energy X-ray densitometry data were analyzed, as well as indicators of activation of lipid peroxidation (malonic aldehyde), antioxidant protection system (superoxide dismutase and SH-group, ceruloplasmin, сatalase) and tissue destruction (oxyproline). The data of correlation and regression analysis between the above mentioned indicators and the main features of chronic pancreatitis and osteodeficiency in patients of the analyzed contingent were demonstrated.
Materials and Methods. The complex examination of 72 patients was made. Patients were divided into two groups: 30 patients with OA and 42 – with OA in combination with CP. The control group included 20 apparently healthy individuals. Evaluation of CT scan was performed using Dual Energy X-Ray Absorptiometry – DXA by Lunar corp. (Madison, WI) - Lunar DPX-A No. 2589 in the lumbar region of the vertebral column. The evaluation of the indicators was carried out in accordance with WHO recommendations (WHO, Geneva, 1994) [19]. The study of LPO was carried out on the level of malonic aldehyde (MA). To assess AOP, we determined SOD, ceruloplasmin (CPN); SH-groups; catalase. The endogenous intoxication and the level of degradation of the connective tissue in the body was estimated by levels of free oxyproline. The influence of CP on the state of LPO-AOP was established by the following clinical characteristics of CP: age of the patients, structural condition of the pancreas with the help of the method of ultrasound, expressed in points. Excretory function of the pancreas was investigated on the level of fecal α-elastase ( by ELISA test using the kits BIOSERV ELASTASE 1-ELISA).
Results. During the examination of the mineral bone density by the dual energy X-ray densitometry it was discovered that the presence of CP in patients with OA led to a significant reduction of BMD and deterioration of the bone tissue (BT): the proportion of patients with normal bone decreased from 67 % to 16 %, the number of patients with osteopenia increased from 10 % to 67 %; patients with OP appeared – 17%.Besides, the increased degradation of bone tissue in OA with CP was accompanied by strengthening of oxidative changes (by MA-level), weakening of the antioxidant defense (SOD and SH-groups), the increase in the severity of inflammation and endotoxemia (levels of catalase and ceruloplasmin), as well as increased degradation of connective and bone tissue in the joints and progression of fibrosis in tissue (the level of oxyproline).
Conclusions. It was found out that the presence of CP in patients with OA led to a significant reduction of BMD and the deterioration of the bone tissue. It was discovered that during the combined course of OA and CP with osteopenia there occurs the weakening of the AOP (by SOD and SH-groups) and a relatively high level of LPO activation (by MA-level) as well as the increased deterioration in connective and bone tissue and aggravation of osteopenia which is indicated by the increased levels of oxyproline.
References
Alieksieiva, L. I. (2003). Osteoartroz i osteoporoz: [Osteoarthritis and osteoporosis]. Rukovodstvo po osteoporozu. L. I. Benevolencka Moscow: Binom [in Russian].
Babinets, L. C. (2008). Vzaiemozviazok stanu kistkovoi tkanyny, parametriv anemii ta bilkovogo status pry khronichnomu pankreatyti. [The relationship between bone condition and parameters of anemia and protein status in chronic pancreatitis]. Ukrainskyi morfologichnyi almanakh - Ukrainian morphological almanac, 3, 93-95 [in Ukrainian].
Vertkyn, A. L., & Naumov, A. V., (2007). Deformuiuchyi osteoartroz: strategiia vedennia patsiientiv pry somatychnii patologii. [Deforming osteoarthritis: a strategy for the management of patients with somatic pathology]. Rosiiskyi medychnyi zhurnal - Russian medical journal [in Russian].
Gaidaiev, Yu. A., Kovalenko, V. M., & Kornatskyi,V. M., (2014). Stan zdorovia naselennia Ukrainy ta zabezpechennia nadannia medychnoi dopomogy. [The state of health of the Ukrainian population and provide medical assistance]. Analitychno-statystychnyii posibnyk - analytically – statistical Handbook Kyiv, 97 [in Ukrainian].
Gaiko, G. V., Brusko, A. T., & Kalashnikov, O. V., (2014). Osoblyvosti patomorfologichnykh zmin golovky stegnovoi kistky u chvorych na osteoartroz kulshovogo sugloba. [Features of pathological changes of the femoral head in patients with osteoarthritis of the hip joint]. Bil. Suglloby. Chrebet - Pain. Joints. Spine. ,1/2, 9-13 [in Ukrainian].
Kazemirko, V. K., Kovalenko, O. P., & Flegontova, V. V., (2011). Involiutsiinyi osteoartroz i osteoporoz. [Involutional osteoarthritis and osteoporosis.]. Donetsk [in Ukrainian].
Kovalenko, V. N., & Bortkevych, O. P., (2003). Osteoporoz. Praktychnyi posibnyk. [Osteoporosis. A practical guide.]. Kyiv: Morion [in Ukrainian].
Lazebnik, L.D., & Drozdov, V. N., (2003). Zabolevaniia organov pishchevareniia u pozhelych. [Diseases of the digestive system in the elderly]. Moscow: Anacharsis [in Russian].
Nasonov, V.I., (2009). Osteoartroz – problem polimorbidnosti. [Osteoarthritis – a problem polymorbidity]. Ukrainckyi medychnyi chasopys - Ukrainian medical journal, 6, 81-84 [in Ukrainian].
Unifikovanyi klinichnyi protocol pervynnoi, vtorynnoi (spetsializovanoi) medychnoi dopomogy ta medychnoi reabilitatsii. [Unified clinical Protocol of primary, secondary (specialized) medical care and rehabilitation] (2014). № 638 Ministerstvo okhorony zdorovia Ukrainy - The Ministry of health of Ukraine [in Ukrainian].
Tkachenko, L.A., Katerenchuk, I.P., Yarmola, T.I., Pustovoit, A.L., & Yermalynskyi, F.A., (2010). Urazhennia shlunkovo-kyshkovogo traktu pry osteoartrosi. [Lesions of the gastrointestinal tract in osteoarthritis]. Svit medytsyny ta biologii - The world of medicine and biology, 2, 183-186 [in Ukrainian].
Pasiieshvili, L.M., Bobrov, L.M., & Morgulis, M.V., (2008). Poryshennia kaltsiievogo obminu iak predyktor formuvannia vtorynnogo osteoporpzu u khvorykh na khronichnyi pankreatyt. [Violation of calcium metabolism as a predictor of the formation of secondary osteoporosis in patients with chronic pancreatitis.]. Suchasna gastroenterologiia – Modern gastroenterology, 3(41), 4-8 [in Ukrainian].
Smetnyk, V.P., (2010). Problema osteoporoza: novye terapevticheskie resheniia I dolgovremennaia klinicheskaia efektivnost. [The problem of osteoporosis: new therapeutic solutions and long-term clinical efficacy]. Konsilium medikum - Consilium Medicum. 6, 13-16 Moscow [in Russian].
Mostovyi, Yu. M., (2012). Suchasni klasyfikatsii ta standarty likuvannia rozpovsiudzhenych zachvoriuvan vnutrishnich organiv. [Modern classification and treatment of common diseases of internal organs]. Vinnytsa:DP «DKF», 576 [in Ukrainian].
Castaneda, S., Roman-Blas, J. A., Largo, R. et al. (2012). Subchondral bone as a key target for osteoarthritis treatment. Biochem. Pharmacol., 315-323.
Fernandes, L., Lund, H., Mallen, C.D. et al. (2012). EULAR recommendations for the non-pharmacological core management of hip and knee osteoarthritis. Ann. Rheum. Dis. doi: 10.1136/annrheumdis-2012-202745.
Hochberg, M. (2012). Osteoarthritis year 2012 in review: clinical. Osteoarthritis Cartilage, 20, 1465-1469.
Neogi, T. (2012). Clinical significance of bone changes in osteoarthritis. Ther. Adv. Musculoskelet. Dis., 4, 259-267.
World Health Organization:Assessement of fracture risk and its application to screening for postmenopausal osteoporosis. WHO Technical Report Series 843. WHO, Geneva,1994.
Wright, S.E., Lochan, R., Imrie, K., Baker, C., Nesbitt, I.D., Kilner, A.J. et al. (2009). Quality of life and functional outcome at 3, 6 and 12 months after acute necrotising pancreatitis. Intensive Care Med., 8, 37-44.
